Cargando…
Synchronous triple primary malignant tumours in the bladder, prostate, and lung harbouring TP53 and MEK1 mutations accompanied with severe cardiovascular diseases: A case report
Although the incidence of multiple primary malignancies (MPMs) is increasing, synchronous triple primary malignant tumours with prostate, bladder and lung is rarely reported. Gene mutation is thought to be a reason for MPMs, and severe cardiovascular diseases may interrupt the cancer treatment. Here...
Autores principales: | Li, Zhi-Ke, Zhao, Qiang, Li, Ning-Fu, Wen, Jing, Tan, Bang-Xian, Ma, Dai-Yuan, Du, Guo-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755706/ https://www.ncbi.nlm.nih.gov/pubmed/36568519 http://dx.doi.org/10.1515/med-2022-0616 |
Ejemplares similares
-
Nutlin‐3a selects for cells harbouring TP
53 mutations
por: Kucab, Jill E., et al.
Publicado: (2016) -
Synchronous primary triple urogenital malignant tumors of kidney, prostate and bladder
por: Kurose, Hirofumi, et al.
Publicado: (2020) -
Triple Synchronous Urogenital Malignancies of the Bladder, Kidney, and Prostate: Management in a Single Operation
por: Perry, Kyler W, et al.
Publicado: (2023) -
Synchronous tumours of the breast and bladder
por: Wallace, David, et al.
Publicado: (2014) -
Impact of TP53 mutations in Triple Negative Breast Cancer
por: Mitri, Zahi I., et al.
Publicado: (2022)